Hana Pharm Co., Ltd. (KRX:293480)

Hana Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2017	FY 2016
Period Ending	Dec 31, 2017	Dec 31, 2016
Operating Revenue	139,331	124,535
Other Revenue	-0	-
Revenue	139,331	124,535
Revenue Growth (YoY)	11.88%	-
Cost of Revenue	45,328	40,859
Gross Profit	94,003	83,676
Selling, General & Admin	59,248	55,580
Research & Development	2,214	3,424
Other Operating Expenses	137.99	143.58
Operating Expenses	62,192	60,006
Operating Income	31,811	23,671
Interest Expense	-1,044	-1,481
Interest & Investment Income	89.51	81.14
Currency Exchange Gain (Loss)	75.51	-25.86
Other Non Operating Income (Expenses)	-205.42	-166.64
EBT Excluding Unusual Items	30,727	22,078
Gain (Loss) on Sale of Assets	234.01	-19.1
Asset Writedown	-	-108.48
Pretax Income	30,961	21,950
Income Tax Expense	6,658	4,520
Earnings From Continuing Operations	24,302	17,431
Minority Interest in Earnings	2.15	-
Net Income	24,305	17,431
Net Income to Common	24,305	17,431
Net Income Growth	39.43%	-
Shares Outstanding (Basic)	11	8
Shares Outstanding (Diluted)	11	8
Shares Change (YoY)	39.75%	-
EPS (Basic)	2243.00	2248.00
EPS (Diluted)	2243.00	2248.00
EPS Growth	-0.22%	-
Free Cash Flow	15,187	4,154
Free Cash Flow Per Share	1401.56	535.67
Gross Margin	67.47%	67.19%
Operating Margin	22.83%	19.01%
Profit Margin	17.44%	14.00%
Free Cash Flow Margin	10.90%	3.34%
EBITDA	35,333	27,349
EBITDA Margin	25.36%	21.96%
D&A For EBITDA	3,522	3,678
EBIT	31,811	23,671
EBIT Margin	22.83%	19.01%
Effective Tax Rate	21.51%	20.59%
Advertising Expenses	1,858	1,736

Source: S&P Capital IQ. Standard template. Financial Sources.